slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
188,581-188,640 of 319,975
38
Morgan Stanley project slide, likely part of a valuation or M&A deck.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
39
Share counts as of 4/6/2022 Proxy, total share count does not tie to detailed Aggregate Value build as those share counts are as of the 2Q22 filing and detailing sharecount ownership is not provided.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
40
The slide presents a WACC calculation with low, base, and high scenarios, showing inputs like Market Risk Premium, Beta, and Risk-Free Rate.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
41
Morgan Stanley | Investment Banking Pitch Book | 41 slidesMorgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
01
Myovant Sciences | Results Presentation Deck | 34 slidesMyovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
02
Myovant Sciences | Results Presentation Deck | 34 slidesMyovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
03
Myovant Sciences | Results Presentation Deck | 34 slidesMyovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
04
Myovant Sciences | Results Presentation Deck | 34 slidesMyovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
05
The slide emphasizes the 'first and only' status of the drug for these two conditions.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
06
Uses a bar chart visualization to represent patient population segments.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
07
The slide uses icons to represent four distinct pillars of growth: product profile, market synergy, financial milestone, and strategic pipeline expansion.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
08
Myovant Sciences | Results Presentation Deck | 34 slidesMyovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
09
Includes citations for data points.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
Includes a disclaimer about the 24-month usage limit due to bone loss risk.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
11
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
12
Clinical trial data presentation with p-values and sample sizes.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
The slide includes a footnote defining the response rate criteria and a disclaimer that it is not for promotion.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
14
The chart highlights a 74.1% mean reduction in NRS score for MYFEMBREE vs 26.4% for placebo at week 24.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
The slide highlights a 49.7% reduction in NMPP NRS score at week 24 for the pooled MYFEMBREE group compared to 36.0% for placebo.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
The chart highlights a 57.9% mean reduction in pain domain score for the pooled MYFEMBREE group versus 32.6% for placebo at week 24.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
17
The chart shows a greater reduction in pain scores for the treatment group compared to placebo, with p < 0.05 significance indicated for both trials.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Before After1 hit
18
Includes clinical trial data for opioid rescue usage at baseline vs month 6.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
19
Standard pharmaceutical safety disclosure slide.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
20
Clinical safety data table for MYFEMBREE.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
21
Data from SPIRIT 1 and 2 studies only.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
22
The chart shows a decrease in BMD for the treatment group compared to a slight increase for the placebo group.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
23
The slide compares a control/observational group against a treatment group (SPIRIT study) to show BMD changes.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
24
The table presents efficacy percentages for MYFEMBREE vs placebo (in parentheses) for three pain metrics, plus safety data.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Beat · Solution1 hit
25
Myovant Sciences | Results Presentation Deck | 34 slidesMyovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
26
The slide uses a Venn diagram to illustrate the intersection of Efficacy, Safety & Tolerability, and Clear, Simple Dosing.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
27
Myovant Sciences | Results Presentation Deck | 34 slidesMyovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
28
Uses a Venn diagram to illustrate target overlap.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
29
The slide uses a donut chart to visualize the split between initial coverage and ongoing payer discussions.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Beat · Market Size1 hit
30
The slide uses a hub-and-spoke diagram centered on a patient photo to illustrate support services.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
31
The slide uses a visual comparison matrix to highlight the 'one pill, once-a-day' value proposition.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
32
Uses a split-screen layout to contrast 'Today' vs 'Tomorrow' strategic focus areas.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
33
Features four executives with headshots in hexagonal frames.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
34
Myovant Sciences | Results Presentation Deck | 34 slidesMyovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations 1 hit
01
Features a stylized illustration of a crowd forming an X shape.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Setup1 hit
02
Nexters | Results Presentation Deck | 13 slidesNexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Setup1 hit
03
Nexters | Results Presentation Deck | 13 slidesNexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Setup1 hit
04
Nexters | Results Presentation Deck | 13 slidesNexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Setup1 hit
05
The slide uses a side-by-side bar chart comparison for three key financial metrics.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
06
Nexters | Results Presentation Deck | 13 slidesNexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
07
The slide uses bar charts to show year-over-year growth metrics for Nexters.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Evidence1 hit
08
The slide uses stacked bar charts to show composition and YoY growth annotations.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Evidence1 hit
09
The slide uses a split layout: left side details the new director profiles, middle shows associated company logos, and right side lists governance changes.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Development1 hit
10
Nexters | Results Presentation Deck | 13 slidesNexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Development1 hit
11
Financial data presented in thousands of currency units.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Development1 hit
12
The slide presents a standard financial P&L table with two columns for quarterly comparison.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Development1 hit
13
Standard financial reporting table.Nexters | Results Presentation Deck | 13 slides · Nexters
Conference presentation Investor relations Beat · Development1 hit
01
The image features a city skyline with digital overlays suggesting drone navigation and location services.NextNav | Results Presentation Deck | 11 slides · NextNav
Conference presentation Investor relations Beat · Humble Origins1 hit
02
NextNav | Results Presentation Deck | 11 slidesNextNav | Results Presentation Deck | 11 slides · NextNav
Conference presentation Investor relations Beat · Humble Origins1 hit
03
NextNav | Results Presentation Deck | 11 slidesNextNav | Results Presentation Deck | 11 slides · NextNav
Conference presentation Investor relations Beat · Early Struggles1 hit
04
The slide uses a background image of a city street and a series of photos at the bottom representing industries reliant on PNT (aviation, ride-sharing, logistics, mobile, emergency services, shipping).NextNav | Results Presentation Deck | 11 slides · NextNav
Conference presentation Investor relations Beat · Early Struggles1 hit
05
The slide outlines regulatory requirements for FAA systems to move toward resilient, NIST/USNO-traceable timing sources.NextNav | Results Presentation Deck | 11 slides · NextNav
Conference presentation Investor relations Beat · Rising SuccessLoop · Why Now1 hit
06
The slide uses a frequency spectrum diagram to visualize the 8 MHz contiguous block held by NextNav.NextNav | Results Presentation Deck | 11 slides · NextNav
Conference presentation Investor relations Beat · Rising SuccessLoop · Why Now1 hit
07
The slide uses isometric building illustrations to visualize the scale of service coverage (building-wide vs. specific unit).NextNav | Results Presentation Deck | 11 slides · NextNav
Conference presentation Investor relations Beat · Rising SuccessLoop · Why Now1 hit
08
NextNav | Results Presentation Deck | 11 slidesNextNav | Results Presentation Deck | 11 slides · NextNav
Conference presentation Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet1 hit
09
The slide uses a three-column layout to segment partners by industry vertical.NextNav | Results Presentation Deck | 11 slides · NextNav
Conference presentation Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet1 hit